IDEAYA Biosciences (IDYA) Tops Q1 EPS by 5c

IDEAYA Biosciences (NASDAQ: IDYA) reported Q1 EPS of ($0.49), $0.05 better than the analyst estimate of ($0.54). Revenue for the quarter came in at $7.88 million versus the consensus estimate of $7.17 million.

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
• Worthington Enterprises raises dividend 5%, adds board member